Prestige Consumer to Acquire Breathe Right in $1.05B Deal

Deal Summary

Prestige Consumer Healthcare has announced its agreement to acquire the Breathe Right nasal strip brand and other assets from Foundation Consumer Healthcare. The transaction is valued at $1.045 billion, which equates to approximately $900 million after accounting for tax benefits.

Strategic Overview

This acquisition marks Prestige Consumer Healthcare's expansion into a new product category. Following the deal, the Breathe Right brand is projected to become the largest brand within Prestige's portfolio. The transaction is anticipated to be finalized during the first half of 2027.

Financial Impact

The Breathe Right brand reported revenues of about $200 million and a core profit of $95 million in 2025. Prestige Consumer Healthcare expects the acquisition to be accretive to its core profit. This strategic move follows a period where the company surpassed its third-quarter revenue estimates.

Conclusion

Prestige CEO Ron Lombardi stated that the acquisition aligns with the company's disciplined M&A framework and enhances the portfolio for the long-term. Market observers will monitor how the integration of this major brand impacts Prestige's financial performance and market position following the deal's closure.

FAQ

Q: Who is acquiring the Breathe Right brand?
A: Prestige Consumer Healthcare is acquiring the Breathe Right brand from Foundation Consumer Healthcare.

Q: What is the total value of the acquisition?
A: The deal is valued at $1.045 billion before tax benefits.

Q: When is the deal expected to close?
A: The transaction is expected to close during the first half of 2027.

Source: Investing.com